Dri Healthcare Trust T.DHT.UN

Alternate Symbol(s): DHTRF

Healthcare Biotechnology

DRI Healthcare Trust is a Canada-based company engaged in global pharmaceutical royalty monetization. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It acquires more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. Its portfolio includes Empaveli/Syfovre, Eylea I, Eylea II, Ilaris, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Simponi, Spinraza, Stelara, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, Zytiga, sebetralstat, and others. Its therapeutic areas include hematology, ophthalmology, influenza, endocrinology, dermatology, oncology, neurology, immunology, lysosomal storage disorder, hereditary angioedema, and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; and others.

TSX:DHT.UN - Post by User

Dri Healthcare Trust

<< Previous

Bullboard Posts

Next >>

(64)
•••

Post by SONOFFERGUSon Sep 25, 2024 5:08pm

136 Views

Post# 36241040

Scotia Hearts DHT (or did today, at least)

Tomorrow will be an interesting day.

Will fundamentals prevail?

Will shorts capitulate?

Will weak hands find some fortitude?

Will chartists and momentum players jump on?

I remain on the train but may lighten up if units can't breach $13 and hold.

<< Previous

Bullboard Posts

Next >>

Hydrogen at a crossroads: Plug Power, Pure Hydrogen and Nel ASA between opportunity and crisis – Your profit strategy